Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa)

Conclusion: Cardiovascular risk factors, deregulated blood glucose, uric acid metabolism, and inflammation were identified as risk markers for faster disease progression. Our panel of risk parameters needs validation during our continuing follow ‐up and also in independent patient cohorts. © 2018 International Parkinson and Movement Disorder Society

Source: Movement Disorders - November 23, 2018 Category: Neurology Authors: Brit Mollenhauer, Johannes Zimmermann, Friederike Sixel ‐Döring, Niels K. Focke, Tamara Wicke, Jens Ebentheuer, Martina Schaumburg, Elisabeth Lang, Tim Friede, Claudia Trenkwalder, on behalf of the DeNoPa Study Group Tags: Research Article Source Type: research